Who owns EUPRAXIA PHARMACEUTICALS INC?
- Ticker: EPRX
- CUSIP Number: 29842p105
Tip: Access positions for across all investors
Analyze quarterly positions in Eupraxia Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eupraxia Pharmaceuticals stock
Who bought or sold EUPRAXIA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Scotia Capital | 1.4M | $3.5M | 100% | Sep 2024 |
|
| Royal Bank of Canada | 271k | $714k | 2% | Sep 2024 |
|
| Bank Of Montreal | 49k | $126k | 100% | Sep 2024 |
|
| Goldman Sachs Group | 35k | $91k | 100% | Sep 2024 |
|
| UBS Group | 33k | $87k | 12% | Sep 2024 |
|
| 180 Wealth Advisors | 11k | $33k | -19% | Dec 2024 |
|
| TD Waterhouse Canada | 1.5k | $3.8k | 100% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 150.00 | $394.005000 | 100% | Sep 2024 |
|
Who sold out of Eupraxia Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Jun 2024 | 1.9k | $4.9k |
| Federation des caisses Desjardins du Quebec | Jun 2024 | 545.00 | $1.4k |